The SK pharmteco group is now offering a standardized viral vector and plasmid manufacturing process to a global audience. The global approach can help customers move to batches for clinical trials in ...
SAN FRANCISCO--(BUSINESS WIRE)--Vector Capital, a leading investment firm specializing in transformational investments in established technology businesses, today announced that it has successfully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback